MISSION
Autarcycle comes from the fusion between the words autarky, that describe a self-sufficient economic system, and cycle, that describe an uninterrupted series of phenomenon that renew in an unalterable order.
We work with our partners in order to promote, develop and share products that give durable and environmentally acceptable automated microproduction technologies and to promote, develop and share knowledge in health, science and education.
PRODUCTS
BIOFUEL AUTOMATED MICRO-FACTORIES
SERVICES
RESEARCH AND DEVELOPMENT
The CHEMATETM project lead the ambitious task of creating automated microfactories that will allowed delocalized autonomous environmental production.
CHEMATETM come from the fusion between the words chemistry, that describe the scientific discipline involved with behavior and changes of substances composed of atoms, molecules and/or ions, and mate, that describe a fellow member or joint occupant of a specified thing.
CONTACT
Autarcycle Inc.
534 de la chevauchée,
Lévis, Québec, Canada,
G6C-1W8.
Tel: 581-745-1080.
alain.rouillard@autarcycle.com
ABOUT US
Chief Executive Officer
Alain Rouillard, Pharm.D., Ph.D.
Dr. Rouillard is the Founder, President, and Chief Executive Officer (CEO) of Autarcycle since its foundation in 2009.
He obtained his Ph.D. in Chemistry in 2003 under the supervision of Pr. Pierre Deslongchamps at the Université de Sherbrooke. There, he helped to develop new synthetic methods which were published in peer-reviewed journals and ever since cited in the literature.
As an organic synthesis specialist, throughout his early career, he participated in several chemical synthesis programs for various big pharma companies (Merck, Servier, AstraZeneca), small biotechs (Tranzyme Pharma, CIMF), and contract research organizations (CROs) (OmegaChem), leading to several patents and publications in peer-reviewed journals and real life application of chemical synthesis.
While working on the foundation of the Autarcycle company, Dr. Rouillard obtained his Pharm.D. in 2015, closing the loop of the pharmaceutical industry, from basic research to the clinical distribution of its products.
His extensive scientific expertise in the pharmaceutical industry and hard work, applied to the development of durable and environmentally acceptable automated micro-production technology, yielded the development of a new patented chemical process that allowed the development of an entirely automated biofuel micro-factory. The lead product that is set to drive Autarcycle’s growth.
His vision of a debt-free company that fulfills its social, scientific, and technological mission, free from external influence, and his patience have ensure Autarcycle longevity by creating an important Polymath Private IP Portfolio.